Literature DB >> 7660750

Bio-/haemocompatibility: implications and outcomes for sensors?

M Kyrolainen1, P Rigsby, S Eddy, P Vadgama.   

Abstract

Sensors are a sample contacting technology, and when exposed to biological matrices tend to suffer from the problem of poor biocompatibility and surface fouling. The effects are evidenced by time dependent signal drift (particularly for those devices which are implanted intravascularly). Practical methods to reduce such effects require an understanding of the interface between the electrode and its environment prior to assessment of the potential areas for improvement. Current procedures employed to overcome the observed losses in electrode sensitivity (following exposure to whole blood) include surface modification of the outer diffusion limiting membrane (via variation in film porosity) or even biomimicry of the fluid cell membrane. At amperometric electrodes incorporation of additional inner perm-selective membranes has achieved a reduction in electrode passivation from undesirable surface active compounds as has the use of low polarisation potentials. Other studies have attempted to induce an aqueous barrier between the matrix and the electrode tip which physically prevents passage of cellular components from the sensor surface. Careful choice of the system and materials will ultimately lead to biocompatible non-fouling devices capable of functioning in an array of bio-environments suitable for clinical monitoring of the critically ill patient.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660750     DOI: 10.1111/j.1399-6576.1995.tb04255.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand Suppl        ISSN: 0515-2720


  11 in total

1.  Evaluation of microfluidic blood gas sensors that combine microdialysis and optical monitoring.

Authors:  C G Cooney; B C Towe
Journal:  Med Biol Eng Comput       Date:  2004-09       Impact factor: 2.602

Review 2.  A tale of two compartments: interstitial versus blood glucose monitoring.

Authors:  Eda Cengiz; William V Tamborlane
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

3.  Peptide-based Biopolymers in Biomedicine and Biotechnology.

Authors:  Dominic Chow; Michelle L Nunalee; Dong Woo Lim; Andrew J Simnick; Ashutosh Chilkoti
Journal:  Mater Sci Eng R Rep       Date:  2008-01       Impact factor: 36.214

4.  Anti-inflammatory polymeric coatings for implantable biomaterials and devices.

Authors:  Amanda W Bridges; Andrés J García
Journal:  J Diabetes Sci Technol       Date:  2008-11

Review 5.  Biomaterials/tissue interactions: possible solutions to overcome foreign body response.

Authors:  Jacqueline M Morais; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

6.  A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.

Authors:  Yoshinori Onuki; Upkar Bhardwaj; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  J Diabetes Sci Technol       Date:  2008-11

Review 7.  New-generation diabetes management: glucose sensor-augmented insulin pump therapy.

Authors:  Eda Cengiz; Jennifer L Sherr; Stuart A Weinzimer; William V Tamborlane
Journal:  Expert Rev Med Devices       Date:  2011-07       Impact factor: 3.166

8.  Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems.

Authors:  Cosimo Scuffi
Journal:  Eur Endocrinol       Date:  2014-02-28

9.  Enhancing the sensitivity of needle-implantable electrochemical glucose sensors via surface rebuilding.

Authors:  Santhisagar Vaddiraju; Allen Legassey; Liangliang Qiang; Yan Wang; Diane J Burgess; Fotios Papadimitrakopoulos
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

Review 10.  Emerging synergy between nanotechnology and implantable biosensors: a review.

Authors:  Santhisagar Vaddiraju; Ioannis Tomazos; Diane J Burgess; Faquir C Jain; Fotios Papadimitrakopoulos
Journal:  Biosens Bioelectron       Date:  2009-12-11       Impact factor: 10.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.